Improving smoking cessation after myocardial infarction by systematically implementing evidence-based treatment methods
We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of evidence-based smoking cessation methods, with start during admission. The following routines were implemented at six Swedish hospitals: cardiac rehabilitat...
Saved in:
| Published in | Scientific reports Vol. 12; no. 1; pp. 642 - 9 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
12.01.2022
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2045-2322 2045-2322 |
| DOI | 10.1038/s41598-021-04634-5 |
Cover
| Abstract | We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of evidence-based smoking cessation methods, with start during admission. The following routines were implemented at six Swedish hospitals: cardiac rehabilitation nurses offering smokers consultation during admission, optimizing nicotine replacement therapy and varenicline prescription, and contacting patients by telephone during the 1st week post-discharge. Using logistic regression, odds for smoking cessation at 2-months before (n smokers/n admitted = 188/601) and after (n = 195/632) routine implementation were compared. Secondary outcomes included adherence to implemented routines and assessing the prognostic value of each routine on smoking cessation. After implementation, a larger proportion of smokers (65% vs. 54%) were abstinent at 2-months (OR 1.60 [1.04–2.48]). Including only those counselled during admission (n = 98), 74% were abstinent (2.50 [1.42–4.41]). After implementation, patients were more often counselled during admission (50% vs. 6%,
p
< 0.001), prescribed varenicline (23% vs. 7%,
p
< 0.001), and contacted by telephone post-discharge (18% vs. 2%,
p
< 0.001). Being contacted by telephone post-discharge (adjusted OR 2.74 [1.02–7.35]) and prescribed varenicline (adjusted OR 0.39 [0.19–0.83]) predicted smoking cessation at 2-months. In conclusion, readily available methods for aiding smoking cessation can be implemented effectively in routine practice, with beneficial effects for post-MI patients. |
|---|---|
| AbstractList | We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of evidence-based smoking cessation methods, with start during admission. The following routines were implemented at six Swedish hospitals: cardiac rehabilitation nurses offering smokers consultation during admission, optimizing nicotine replacement therapy and varenicline prescription, and contacting patients by telephone during the 1st week post-discharge. Using logistic regression, odds for smoking cessation at 2-months before (n smokers/n admitted = 188/601) and after (n = 195/632) routine implementation were compared. Secondary outcomes included adherence to implemented routines and assessing the prognostic value of each routine on smoking cessation. After implementation, a larger proportion of smokers (65% vs. 54%) were abstinent at 2-months (OR 1.60 [1.04–2.48]). Including only those counselled during admission (n = 98), 74% were abstinent (2.50 [1.42–4.41]). After implementation, patients were more often counselled during admission (50% vs. 6%,
p
< 0.001), prescribed varenicline (23% vs. 7%,
p
< 0.001), and contacted by telephone post-discharge (18% vs. 2%,
p
< 0.001). Being contacted by telephone post-discharge (adjusted OR 2.74 [1.02–7.35]) and prescribed varenicline (adjusted OR 0.39 [0.19–0.83]) predicted smoking cessation at 2-months. In conclusion, readily available methods for aiding smoking cessation can be implemented effectively in routine practice, with beneficial effects for post-MI patients. We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of evidence-based smoking cessation methods, with start during admission. The following routines were implemented at six Swedish hospitals: cardiac rehabilitation nurses offering smokers consultation during admission, optimizing nicotine replacement therapy and varenicline prescription, and contacting patients by telephone during the 1st week post-discharge. Using logistic regression, odds for smoking cessation at 2-months before (n smokers/n admitted = 188/601) and after (n = 195/632) routine implementation were compared. Secondary outcomes included adherence to implemented routines and assessing the prognostic value of each routine on smoking cessation. After implementation, a larger proportion of smokers (65% vs. 54%) were abstinent at 2-months (OR 1.60 [1.04–2.48]). Including only those counselled during admission (n = 98), 74% were abstinent (2.50 [1.42–4.41]). After implementation, patients were more often counselled during admission (50% vs. 6%, p < 0.001), prescribed varenicline (23% vs. 7%, p < 0.001), and contacted by telephone post-discharge (18% vs. 2%, p < 0.001). Being contacted by telephone post-discharge (adjusted OR 2.74 [1.02–7.35]) and prescribed varenicline (adjusted OR 0.39 [0.19–0.83]) predicted smoking cessation at 2-months. In conclusion, readily available methods for aiding smoking cessation can be implemented effectively in routine practice, with beneficial effects for post-MI patients. We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of evidence-based smoking cessation methods, with start during admission. The following routines were implemented at six Swedish hospitals: cardiac rehabilitation nurses offering smokers consultation during admission, optimizing nicotine replacement therapy and varenicline prescription, and contacting patients by telephone during the 1st week post-discharge. Using logistic regression, odds for smoking cessation at 2-months before (n smokers/n admitted = 188/601) and after (n = 195/632) routine implementation were compared. Secondary outcomes included adherence to implemented routines and assessing the prognostic value of each routine on smoking cessation. After implementation, a larger proportion of smokers (65% vs. 54%) were abstinent at 2-months (OR 1.60 [1.04-2.48]). Including only those counselled during admission (n = 98), 74% were abstinent (2.50 [1.42-4.41]). After implementation, patients were more often counselled during admission (50% vs. 6%, p < 0.001), prescribed varenicline (23% vs. 7%, p < 0.001), and contacted by telephone post-discharge (18% vs. 2%, p < 0.001). Being contacted by telephone post-discharge (adjusted OR 2.74 [1.02-7.35]) and prescribed varenicline (adjusted OR 0.39 [0.19-0.83]) predicted smoking cessation at 2-months. In conclusion, readily available methods for aiding smoking cessation can be implemented effectively in routine practice, with beneficial effects for post-MI patients. Abstract We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of evidence-based smoking cessation methods, with start during admission. The following routines were implemented at six Swedish hospitals: cardiac rehabilitation nurses offering smokers consultation during admission, optimizing nicotine replacement therapy and varenicline prescription, and contacting patients by telephone during the 1st week post-discharge. Using logistic regression, odds for smoking cessation at 2-months before (n smokers/n admitted = 188/601) and after (n = 195/632) routine implementation were compared. Secondary outcomes included adherence to implemented routines and assessing the prognostic value of each routine on smoking cessation. After implementation, a larger proportion of smokers (65% vs. 54%) were abstinent at 2-months (OR 1.60 [1.04–2.48]). Including only those counselled during admission (n = 98), 74% were abstinent (2.50 [1.42–4.41]). After implementation, patients were more often counselled during admission (50% vs. 6%, p < 0.001), prescribed varenicline (23% vs. 7%, p < 0.001), and contacted by telephone post-discharge (18% vs. 2%, p < 0.001). Being contacted by telephone post-discharge (adjusted OR 2.74 [1.02–7.35]) and prescribed varenicline (adjusted OR 0.39 [0.19–0.83]) predicted smoking cessation at 2-months. In conclusion, readily available methods for aiding smoking cessation can be implemented effectively in routine practice, with beneficial effects for post-MI patients. We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of evidence-based smoking cessation methods, with start during admission. The following routines were implemented at six Swedish hospitals: cardiac rehabilitation nurses offering smokers consultation during admission, optimizing nicotine replacement therapy and varenicline prescription, and contacting patients by telephone during the 1st week post-discharge. Using logistic regression, odds for smoking cessation at 2-months before (n smokers/n admitted = 188/601) and after (n = 195/632) routine implementation were compared. Secondary outcomes included adherence to implemented routines and assessing the prognostic value of each routine on smoking cessation. After implementation, a larger proportion of smokers (65% vs. 54%) were abstinent at 2-months (OR 1.60 [1.04-2.48]). Including only those counselled during admission (n = 98), 74% were abstinent (2.50 [1.42-4.41]). After implementation, patients were more often counselled during admission (50% vs. 6%, p < 0.001), prescribed varenicline (23% vs. 7%, p < 0.001), and contacted by telephone post-discharge (18% vs. 2%, p < 0.001). Being contacted by telephone post-discharge (adjusted OR 2.74 [1.02-7.35]) and prescribed varenicline (adjusted OR 0.39 [0.19-0.83]) predicted smoking cessation at 2-months. In conclusion, readily available methods for aiding smoking cessation can be implemented effectively in routine practice, with beneficial effects for post-MI patients.We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of evidence-based smoking cessation methods, with start during admission. The following routines were implemented at six Swedish hospitals: cardiac rehabilitation nurses offering smokers consultation during admission, optimizing nicotine replacement therapy and varenicline prescription, and contacting patients by telephone during the 1st week post-discharge. Using logistic regression, odds for smoking cessation at 2-months before (n smokers/n admitted = 188/601) and after (n = 195/632) routine implementation were compared. Secondary outcomes included adherence to implemented routines and assessing the prognostic value of each routine on smoking cessation. After implementation, a larger proportion of smokers (65% vs. 54%) were abstinent at 2-months (OR 1.60 [1.04-2.48]). Including only those counselled during admission (n = 98), 74% were abstinent (2.50 [1.42-4.41]). After implementation, patients were more often counselled during admission (50% vs. 6%, p < 0.001), prescribed varenicline (23% vs. 7%, p < 0.001), and contacted by telephone post-discharge (18% vs. 2%, p < 0.001). Being contacted by telephone post-discharge (adjusted OR 2.74 [1.02-7.35]) and prescribed varenicline (adjusted OR 0.39 [0.19-0.83]) predicted smoking cessation at 2-months. In conclusion, readily available methods for aiding smoking cessation can be implemented effectively in routine practice, with beneficial effects for post-MI patients. |
| ArticleNumber | 642 |
| Author | Hag, Emma Leosdottir, Margret Schlyter, Mona Michelsen, Halldora Ögmundsdottir Wärjerstam, Sanne Wallert, John Larsson, Matz |
| Author_xml | – sequence: 1 givenname: Margret surname: Leosdottir fullname: Leosdottir, Margret email: margret.leosdottir@med.lu.se organization: Department of Clinical Sciences Malmö, Lund University, Department of Cardiology, Skane University Hospital – sequence: 2 givenname: Sanne surname: Wärjerstam fullname: Wärjerstam, Sanne organization: Department of Cardiology, Skane University Hospital – sequence: 3 givenname: Halldora Ögmundsdottir surname: Michelsen fullname: Michelsen, Halldora Ögmundsdottir organization: Department of Clinical Sciences Malmö, Lund University, Department of Internal Medicine, Helsingborg Hospital – sequence: 4 givenname: Mona surname: Schlyter fullname: Schlyter, Mona organization: Department of Cardiology, Skane University Hospital – sequence: 5 givenname: Emma surname: Hag fullname: Hag, Emma organization: Department of Internal Medicine, County Hospital Ryhov – sequence: 6 givenname: John surname: Wallert fullname: Wallert, John organization: Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet – sequence: 7 givenname: Matz surname: Larsson fullname: Larsson, Matz organization: Clinical Health Promotion Centre, Lund University, The Heart, Lung and Physiology Clinic, Örebro University Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35022490$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-96729$$DView record from Swedish Publication Index http://kipublications.ki.se/Default.aspx?queryparsed=id:148583123$$DView record from Swedish Publication Index |
| BookMark | eNp9k01v1DAQhiNUREvpH-CAInHhQMB2_BFfkKryVakSF-A6cuzJ1m0SL3a21f57nN0tdCu1udjyPPPO63HmZXEwhhGL4jUlHyipm4-JU6GbijBaES5rXolnxREjXFSsZuzg3v6wOEnpiuRPMM2pflEc1oIwxjU5Km7Ph2UMN35clGkI1_NqMSUz-TCWppswlsM6WBOdN33px85Eu4m16zKt04RDRq3p-3Xph2WPA47TLII33uFosWpNQldOEc00x8oBp8vg0qvieWf6hCe79bj49fXLz7Pv1cWPb-dnpxeVVURMFWu1a1RDecMQa0WIo5gjTFkpEbkzlGutjWsdU4gd01hz7WinubWKEVofF-dbXRfMFSyjH0xcQzAeNgchLsDEfIMeQTROc9cQ1xnkLbVGG9pIIwmvJaW8y1rVVivd4nLV7qntjq7zDoELyZq5tnmUX4Y4mR4iJswdvYR-NSdmqs_dnBucoCMKnTECKOMtcKkcaMopUEeZFcrUlItc4_2jNT7736ebG4a4Ai0V0xn_tMUzO6Cz-UVitrHnbC8y-ktYhBtolBCqmeu92wnE8GeFaYLBJ4t9b0YMqwRMUi04Y1Jl9O0D9Cqs4phfe0MRIbmUmXpz39E_K3e_aAaaLWBjSCliB9ZPmxZlg74HSmAeCNgOBOSBgM1AwGyWPUi9U38yqd51NMPjAuN_209k_QVupCIw |
| CitedBy_id | crossref_primary_10_3389_fpubh_2025_1433307 crossref_primary_10_1016_j_jfma_2023_03_016 crossref_primary_10_1097_MS9_0000000000001333 crossref_primary_10_1093_ehjopen_oeae028 |
| Cites_doi | 10.1016/S0140-6736(06)69249-0 10.1097/01.hjr.0000192742.81231.91 10.1002/14651858.CD009329.pub2 10.1186/1471-2458-13-592 10.1093/eurheartj/ehab484 10.1001/jama.290.1.86 10.1093/eurheartj/eht538 10.1097/01.JAA.0000520530.80388.2f 10.1136/thorax.55.12.987 10.1093/eurheartj/ehw106 10.1016/j.ijcard.2018.01.064 10.1177/2047487320913379 10.1161/JAHA.115.002849 10.1016/0735-1097(93)90598-u 10.1161/CIRCULATIONAHA.115.019634 10.4103/0974-7788.59946 10.1161/CIRCULATIONAHA.109.891523 10.1177/2047487318825350 10.1503/cmaj.170377 10.4040/jkan.2013.43.4.557 10.1001/jama.283.24.3244 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| CorporateAuthor | Lunds universitet Profile areas and other strong research environments Department of Clinical Sciences, Malmö Lund University Strategiska forskningsområden (SFO) EpiHealth: Epidemiology for Health Faculty of Medicine Internmedicin - epidemiologi Strategic research areas (SRA) Medicinska fakulteten Profilområden och andra starka forskningsmiljöer Internal Medicine - Epidemiology Institutionen för kliniska vetenskaper, Malmö |
| CorporateAuthor_xml | – name: Faculty of Medicine – name: Medicinska fakulteten – name: Strategiska forskningsområden (SFO) – name: EpiHealth: Epidemiology for Health – name: Internal Medicine - Epidemiology – name: Institutionen för kliniska vetenskaper, Malmö – name: Strategic research areas (SRA) – name: Lunds universitet – name: Profilområden och andra starka forskningsmiljöer – name: Lund University – name: Profile areas and other strong research environments – name: Internmedicin - epidemiologi – name: Department of Clinical Sciences, Malmö |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM AABEP ADTPV AOWAS D8T D91 ZZAVC AGCHP D95 DOA |
| DOI | 10.1038/s41598-021-04634-5 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection (subscription) ProQuest Central Natural Science Collection ProQuest One Community College Coronavirus Research Database ProQuest Central ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest - Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Örebro universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Örebro universitet SwePub Articles full text SWEPUB Lunds universitet full text SWEPUB Lunds universitet DOAJ |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 9 |
| ExternalDocumentID | oai_doaj_org_article_58d94d80dfae4b1ca9a186a60436114f oai_swepub_ki_se_456281 oai_portal_research_lu_se_publications_f07edaa5_124b_467d_9141_1d12c57a3145 oai_DiVA_org_oru_96729 PMC8755785 35022490 10_1038_s41598_021_04634_5 |
| Genre | Journal Article |
| GeographicLocations | Sweden |
| GeographicLocations_xml | – name: Sweden |
| GrantInformation_xml | – fundername: Pfizer funderid: http://dx.doi.org/10.13039/100004319 – fundername: Lund University – fundername: Swedish Heart and Lung Association – fundername: ; |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD COVID K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 PUEGO 5PM AABEP ADTPV AOWAS D8T D91 EJD IPNFZ RIG ZZAVC AGCHP D95 |
| ID | FETCH-LOGICAL-c705t-2b9d8781482ee3700d1ec7027c66ee4da14999adbd27eef29e349d1f94cc72013 |
| IEDL.DBID | 7X7 |
| ISSN | 2045-2322 |
| IngestDate | Wed Aug 27 01:29:33 EDT 2025 Wed Sep 24 03:47:26 EDT 2025 Tue Sep 09 22:33:12 EDT 2025 Tue Sep 09 23:46:47 EDT 2025 Thu Aug 21 18:11:10 EDT 2025 Fri Sep 05 00:09:13 EDT 2025 Wed Aug 13 04:33:05 EDT 2025 Wed Feb 19 02:09:18 EST 2025 Tue Jul 01 01:34:13 EDT 2025 Thu Apr 24 23:07:02 EDT 2025 Fri Feb 21 02:39:27 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2022. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c705t-2b9d8781482ee3700d1ec7027c66ee4da14999adbd27eef29e349d1f94cc72013 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2619056466?pq-origsite=%requestingapplication% |
| PMID | 35022490 |
| PQID | 2619056466 |
| PQPubID | 2041939 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_58d94d80dfae4b1ca9a186a60436114f swepub_primary_oai_swepub_ki_se_456281 swepub_primary_oai_portal_research_lu_se_publications_f07edaa5_124b_467d_9141_1d12c57a3145 swepub_primary_oai_DiVA_org_oru_96729 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8755785 proquest_miscellaneous_2619542267 proquest_journals_2619056466 pubmed_primary_35022490 crossref_citationtrail_10_1038_s41598_021_04634_5 crossref_primary_10_1038_s41598_021_04634_5 springer_journals_10_1038_s41598_021_04634_5 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-12 |
| PublicationDateYYYYMMDD | 2022-01-12 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-12 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Prugger (CR14) 2014; 35 CR19 Critchley, Capewell (CR3) 2003; 290 Vasko (CR6) 2021 Krumholz, Cohen, Tsevat, Pasternak, Weinstein (CR18) 1993; 22 Teo (CR1) 2006; 368 Piepoli (CR9) 2016; 37 Ambrosetti (CR8) 2020 Kong, Ha (CR22) 2013; 43 Kotseva (CR7) 2019; 26 Sterling, Windle, Filion, Touma, Eisenberg (CR12) 2016 West, McNeill, Raw (CR21) 2000; 55 CR4 CR5 Jernberg (CR15) 2018 Snaterse (CR23) 2018; 258 Visseren (CR24) 2021; 42 Olenik, Mospan (CR20) 2017; 30 Windle (CR13) 2018; 190 Cahill, Stevens, Perera, Lancaster (CR10) 2013 Nohlert, Ohrvik, Tegelberg, Tillgren, Helgason (CR25) 2013; 13 Kadam, Bhalerao (CR16) 2010; 1 Quist-Paulsen, Lydersen, Bakke, Gallefoss (CR17) 2006; 13 Chow (CR2) 2010; 121 Eisenberg (CR11) 2016; 133 CK Chow (4634_CR2) 2010; 121 JA Critchley (4634_CR3) 2003; 290 M Ambrosetti (4634_CR8) 2020 P Quist-Paulsen (4634_CR17) 2006; 13 P Vasko (4634_CR6) 2021 MJ Eisenberg (4634_CR11) 2016; 133 LH Sterling (4634_CR12) 2016 FLJ Visseren (4634_CR24) 2021; 42 4634_CR4 SB Windle (4634_CR13) 2018; 190 MF Piepoli (4634_CR9) 2016; 37 4634_CR5 M Snaterse (4634_CR23) 2018; 258 K Kotseva (4634_CR7) 2019; 26 P Kadam (4634_CR16) 2010; 1 JH Kong (4634_CR22) 2013; 43 A Olenik (4634_CR20) 2017; 30 4634_CR19 T Jernberg (4634_CR15) 2018 R West (4634_CR21) 2000; 55 C Prugger (4634_CR14) 2014; 35 E Nohlert (4634_CR25) 2013; 13 KK Teo (4634_CR1) 2006; 368 K Cahill (4634_CR10) 2013 HM Krumholz (4634_CR18) 1993; 22 |
| References_xml | – volume: 368 start-page: 647 year: 2006 end-page: 658 ident: CR1 article-title: Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: A case-control study publication-title: Lancet doi: 10.1016/S0140-6736(06)69249-0 – volume: 13 start-page: 274 year: 2006 end-page: 280 ident: CR17 article-title: Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease publication-title: Eur. J. Cardiovasc. Prev. Rehabil. doi: 10.1097/01.hjr.0000192742.81231.91 – ident: CR4 – year: 2013 ident: CR10 article-title: Pharmacological interventions for smoking cessation: An overview and network meta-analysis publication-title: Cochrane Database Syst. Rev. doi: 10.1002/14651858.CD009329.pub2 – volume: 13 start-page: 592 year: 2013 ident: CR25 article-title: Long-term follow-up of a high- and a low-intensity smoking cessation intervention in a dental setting–a randomized trial publication-title: BMC Public Health doi: 10.1186/1471-2458-13-592 – volume: 42 start-page: 3227 year: 2021 end-page: 3337 ident: CR24 article-title: 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehab484 – volume: 290 start-page: 86 year: 2003 end-page: 97 ident: CR3 article-title: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: A systematic review publication-title: JAMA doi: 10.1001/jama.290.1.86 – volume: 35 start-page: 590 year: 2014 end-page: 598 ident: CR14 article-title: Passive smoking and smoking cessation among patients with coronary heart disease across Europe: Results from the EUROASPIRE III survey publication-title: Eur. Heart J. doi: 10.1093/eurheartj/eht538 – year: 2021 ident: CR6 publication-title: SWEDEHEART Annual report 2020 – volume: 30 start-page: 13 year: 2017 end-page: 19 ident: CR20 article-title: Smoking cessation: Identifying readiness to quit and designing a plan publication-title: JAAPA doi: 10.1097/01.JAA.0000520530.80388.2f – ident: CR19 – volume: 55 start-page: 987 year: 2000 end-page: 999 ident: CR21 article-title: Smoking cessation guidelines for health professionals: An update. Health Education Authority publication-title: Thorax doi: 10.1136/thorax.55.12.987 – volume: 37 start-page: 2315 year: 2016 end-page: 2381 ident: CR9 article-title: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehw106 – volume: 258 start-page: 1 year: 2018 end-page: 6 ident: CR23 article-title: Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2018.01.064 – year: 2020 ident: CR8 article-title: Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology publication-title: Eur. J. Prev. Cardiol. doi: 10.1177/2047487320913379 – year: 2016 ident: CR12 article-title: Varenicline and adverse cardiovascular events: A systematic review and meta-analysis of randomized controlled trials publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.115.002849 – volume: 22 start-page: 1697 year: 1993 end-page: 1702 ident: CR18 article-title: Cost-effectiveness of a smoking cessation program after myocardial infarction publication-title: J. Am. Coll. Cardiol. doi: 10.1016/0735-1097(93)90598-u – volume: 133 start-page: 21 year: 2016 end-page: 30 ident: CR11 article-title: Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.019634 – year: 2018 ident: CR15 publication-title: SWEDEHEART Annual report 2017 – ident: CR5 – volume: 1 start-page: 55 year: 2010 end-page: 57 ident: CR16 article-title: Sample size calculation publication-title: Int. J. Ayurveda Res. doi: 10.4103/0974-7788.59946 – volume: 121 start-page: 750 year: 2010 end-page: 758 ident: CR2 article-title: Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.891523 – volume: 26 start-page: 824 year: 2019 end-page: 835 ident: CR7 article-title: Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry publication-title: Eur. J. Prev. Cardiol. doi: 10.1177/2047487318825350 – volume: 190 start-page: E347 year: 2018 end-page: E354 ident: CR13 article-title: Smoking abstinence 1 year after acute coronary syndrome: Follow-up from a randomized controlled trial of varenicline in patients admitted to hospital publication-title: CMAJ doi: 10.1503/cmaj.170377 – volume: 43 start-page: 557 year: 2013 end-page: 567 ident: CR22 article-title: Effects of a smoking cessation program including telephone counseling and text messaging using stages of change for outpatients after a myocardial infarction publication-title: J. Korean Acad. Nurs. doi: 10.4040/jkan.2013.43.4.557 – volume: 13 start-page: 592 year: 2013 ident: 4634_CR25 publication-title: BMC Public Health doi: 10.1186/1471-2458-13-592 – volume: 133 start-page: 21 year: 2016 ident: 4634_CR11 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.019634 – year: 2020 ident: 4634_CR8 publication-title: Eur. J. Prev. Cardiol. doi: 10.1177/2047487320913379 – volume: 13 start-page: 274 year: 2006 ident: 4634_CR17 publication-title: Eur. J. Cardiovasc. Prev. Rehabil. doi: 10.1097/01.hjr.0000192742.81231.91 – volume: 121 start-page: 750 year: 2010 ident: 4634_CR2 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.891523 – volume-title: SWEDEHEART Annual report 2020 year: 2021 ident: 4634_CR6 – ident: 4634_CR19 doi: 10.1001/jama.283.24.3244 – volume: 43 start-page: 557 year: 2013 ident: 4634_CR22 publication-title: J. Korean Acad. Nurs. doi: 10.4040/jkan.2013.43.4.557 – volume: 258 start-page: 1 year: 2018 ident: 4634_CR23 publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2018.01.064 – volume: 37 start-page: 2315 year: 2016 ident: 4634_CR9 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehw106 – ident: 4634_CR5 – year: 2013 ident: 4634_CR10 publication-title: Cochrane Database Syst. Rev. doi: 10.1002/14651858.CD009329.pub2 – volume-title: SWEDEHEART Annual report 2017 year: 2018 ident: 4634_CR15 – volume: 26 start-page: 824 year: 2019 ident: 4634_CR7 publication-title: Eur. J. Prev. Cardiol. doi: 10.1177/2047487318825350 – volume: 190 start-page: E347 year: 2018 ident: 4634_CR13 publication-title: CMAJ doi: 10.1503/cmaj.170377 – volume: 55 start-page: 987 year: 2000 ident: 4634_CR21 publication-title: Thorax doi: 10.1136/thorax.55.12.987 – volume: 42 start-page: 3227 year: 2021 ident: 4634_CR24 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehab484 – year: 2016 ident: 4634_CR12 publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.115.002849 – ident: 4634_CR4 – volume: 368 start-page: 647 year: 2006 ident: 4634_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(06)69249-0 – volume: 35 start-page: 590 year: 2014 ident: 4634_CR14 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/eht538 – volume: 290 start-page: 86 year: 2003 ident: 4634_CR3 publication-title: JAMA doi: 10.1001/jama.290.1.86 – volume: 30 start-page: 13 year: 2017 ident: 4634_CR20 publication-title: JAAPA doi: 10.1097/01.JAA.0000520530.80388.2f – volume: 1 start-page: 55 year: 2010 ident: 4634_CR16 publication-title: Int. J. Ayurveda Res. doi: 10.4103/0974-7788.59946 – volume: 22 start-page: 1697 year: 1993 ident: 4634_CR18 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/0735-1097(93)90598-u |
| SSID | ssj0000529419 |
| Score | 2.3734076 |
| Snippet | We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of evidence-based... Abstract We compared the odds of smoking cessation at 2-months post-myocardial infarction (MI), before and after implementing routines optimizing use of... |
| SourceID | doaj swepub pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 642 |
| SubjectTerms | 692/308 692/4019 692/499 692/699/75/2 Aged Cardiology and Cardiovascular Disease Cigarette smoking Clinical Medicine Drug addiction Female Heart attacks Humanities and Social Sciences Humans Kardiologi och kardiovaskulära sjukdomar Klinisk medicin Male Medical and Health Sciences Medicin och hälsovetenskap Middle Aged multidisciplinary Myocardial Infarction Nicotine Patients Rehabilitation Science Science (multidisciplinary) Smoking Smoking - adverse effects Smoking cessation Smoking Cessation - methods Sweden - epidemiology Tobacco Use Cessation Devices Varenicline - therapeutic use |
| SummonAdditionalLinks | – databaseName: DOAJ dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDeBFhkJuEBU2_EjPpZHVSHBiaKKi-XYjrpqdrdqdoX239djZ9NdWJUL19hxHM-XzDd-fIPQm8jinRZelkoSXnJLeWk9caUKzMqgdGMtzHd8-y5PTvnXM3G2keoL9oRleeA8cIei9pr7mvjWBt5QZ7WltbQSpNMjl2_h70s02Qimsqo305zq4ZQMqerDPnoqOE3GKOxmrHgptjxREuzfxTL_3iw5rpj-oS6aPNLxA3R_oJL4KL_CQ3QnzB6huzm55Oox-j3OF-B-OocZcQxHApIlcEoNjqer6MkAIR2OQIuQT2XNCt_oO9uuW-HJdNhlDo2EIQ9pCQ7Q43GnOs7JqPsn6PT4y49PJ-WQZqF0iohFyRrta1C-qlkIlSLE0xBLmHJShsB9tF9kkdY3nqkQWqZDxbWnrebOqcgfqqdobzafhecIOydbq2vfUuE5o67hdRNCJEneO6tCWyC6HnLjBg1ySIXRmbQWXtUmm8lEM5lkJiMK9H685zIrcNxa-yNYcqwJ6tnpQsSUGTBl_oWpAu2vcWCGT7o3EGpGtsilLNDrsTh-jLDCYmdhvsx1BJxNVgV6lmEz9qQSQJc0KZDaAtRWV7dLZpPzJPgdY0rQJCrQhzX0brp121C8zfDcesLnyc-jNBjzq6XRMsZWBfq1o16O_swgOXVuuqXpg7ncmEs2LVHBWytM5IiNiR7XG005NdRT5oSyFeWxE-92ND5cuphAmxCD1_TF_zDcS3SPwfEUQkvK9tHe4moZDiJpXDSv0v_hGjfHbos priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKERIXxJtAQUYCLhCIHT_iA0LlUVVIcGJRxcVybIeuyO6WfQj23-OxvSkLq15jJ7HmofnG9nyD0JOA4q3iTpRSVKxkhrDSuMqW0lMjvFStMbDf8emzOB6xjyf8ZA9t2h1lAS52pnbQT2o071_-_rl-Exz-dSoZb14tQhCCQjFK4KJizUp-CV2O50VwlS_D_cT1TRUjKtfO7H51Kz5FGv9d2PP_K5TDOeo_nKMxTh1dR9cywMSHySJuoD0_vYmupJaT61vo17CLgBeTGeyTYygUiPrBsWE4nqxDfAO76XEQSHCEONau8Tnrs-n7NR5P8t1z-IjP3UlLCIsOD_fXcWpRvbiNRkcfvrw7LnPzhdLKii9L2irXAB9WQ72vZVU54sMIlVYI75kLWg3Y0rjWUel9R5WvmXKkU8xaGVBFfQftT2dTfw9ha0VnVOM6wh2jxLasab0P0Mk5a6TvCkQ2Itc2M5NDg4xexxPyutFJTTqoSUc1aV6g58M7Z4mX48LZb0GTw0zg1I4PZvPvOruo5o1TzDWV64xnLbFGGdIII4CkP2SNYZkHGzvQGzvVkIAGDMmEKNDjYTi4KJy7mKmfrdIcDhXLskB3k9kMK6k5gChVFUhuGdTWUrdHpuPTSAMeMk1gKirQi43pnS_rIlE8Tea59Yf346-HURiz-UorETKuAn3bMS-5o85EVKe6X-mF12d_7TDrrpLeGcN1QI6tDnHYaUUY0cQRark0NWFhEc92fDw_-jGGb0Jm3pD7F8v8AbpKoRylIiWhB2h_OV_5hwEkLttH0fP_AHAdaSc priority: 102 providerName: Scholars Portal – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZbxMxELZKKiReEDcLBRkJeIEVa6_Px3BUVSR4gaKKF8tre9uIHFUOofx7PF5nSyCqxOva60w8s57DM98g9DJa8U5zL0opKlYyS1hpfeVKGagVQerGWoh3fP4iTk7Z6IyfHSC6rYVJSfsJ0jId09vssHfLqGigGIwSSEasWclvoEMl4_E7QIfD4ejrqI-swN0VIzpXyFS12vPyjhZKYP37LMx_EyX729K_kEWTNjq-g25nMxIPO8LvooMwu4dudo0lN_fRrz5WgJfTOUTDMZQDJC7g1BYcTzdRi4F0THAUsijuaazZ4CtsZzuZbPB4mjPMYZGQe5CWoPw87rPUcdeIevkAnR5_-vbhpMwtFkonK74qaaO9AtQrRUOoZVV5EuIIlU6IEJiPvIsWpPWNpzKElupQM-1Jq5lzMtoO9UM0mM1n4THCzonWauVbwj2jxDVMNSFEA8l7Z2VoC0S2W25cxh-HNhgTk-7Ba2U6NpnIJpPYZHiB3vTvXHboG9fOfg-c7GcCcnZ6MF-cmyxJhiuvmVeVb21gDXFWW6KEFQDFH33DSObRVg5M_pyXBtzMaCkyIQr0oh-OHyLcrthZmK-7ORzqkmWBHnVi01NSczCVdFUguSNQO6TujszGFwnsO_qTgEdUoLdb0bsi67qteNWJ584vfBx_H6bNmC_WRovoVxXox555nednMtzUhZmszTKYyz_iyKatZPDWchPtw8ZEbeuNJowY4gl1XNqasEjE6z2L50c_x7Am-N-KPPm_P_cU3aJQhFKRktAjNFgt1uFZNA1XzfN8FvwGpwllIg priority: 102 providerName: Springer Nature |
| Title | Improving smoking cessation after myocardial infarction by systematically implementing evidence-based treatment methods |
| URI | https://link.springer.com/article/10.1038/s41598-021-04634-5 https://www.ncbi.nlm.nih.gov/pubmed/35022490 https://www.proquest.com/docview/2619056466 https://www.proquest.com/docview/2619542267 https://pubmed.ncbi.nlm.nih.gov/PMC8755785 https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-96729 http://kipublications.ki.se/Default.aspx?queryparsed=id:148583123 https://doaj.org/article/58d94d80dfae4b1ca9a186a60436114f |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExIviG8CowoS8ALR4sSx4yfUlU1TpU0IGKp4sRzbYRX9oh9C_e-5c9yUQrWXVLId1_Kdc787278j5DWgeCMLyxPBU5YwTVmibWoS4TLNnZCV1hjvuLjk51esPygGIeC2CMcqN99E_6G2U4Mx8mNE-mCsGecfZr8SzBqFu6shhcZtckgBiWDqBjEQbYwFd7EYleGuTJqXxwuwV3inLKN4pjFnSbFjjzxt_z6s-f-RyXbf9B-OUW-Xzu6TewFQxt1GAx6QW27ykNxpUkyuH5HfbdQgXoynGBeP8WKAl0fsE4TH4zXYM9STUQzqBorv66p1vGV51qPROh6Ow1lz7MSFbKQJmkEbt-fV4yYl9eIxuTo7_do7T0KyhcSItFgmWSVtifxXZeZcLtLUUgc1mTCcO8csSBGwpLaVzYRzdSZdzqSltWTGCEAR-RNyMJlO3DMSG8NrLUtb08KyjJqKlZVzAJWsNVq4OiJ0M-XKBCZyTIgxUn5HPC9VIyYFYlJeTKqIyLv2nVnDw3Fj6xOUZNsSObR9wXT-Q4UlqYrSSmbL1NbasYoaLTUtueZIyg9eIgzzaKMHKizshdqqYURetdWwJHGfRU_cdNW0KfCGsojI00Zt2pHkBYImmUZE7CjUzlB3aybDa0_7DZ4lMhNF5P1G9bbDumkq3jTqufMPH4ffun4ypvOVkhw8rIh839Ou8QFVIJ66VqOVWjg1-yuirOpUOKt1oQApVgrsrlWSMqqopZkphM4pg0G83dN5KPo5xD7REy_p85vn_AW5m-H1k5QmNDsiB8v5yr0EULisOn7ld8hht9v_0offk9PLT5-htMd7HR9ogecFK_8A6WxrzQ |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwQviP8EBgSJ8QLRYseJ44cJbWxTx7YKoQ1NezGO7bCKtilNq6lfjs-GL3FSCtXe9ho7zsl3uTvf-e6H0FvrxSse6yRgSUgDKjENpA5VwAyRiWE8kxLiHSe9pHtGP5_H52vod1MLA9cqG51YKWpdKIiRb4Gnb401TZKP418BoEZBdrWB0JAOWkFvVy3GXGHHkZlf2SNcuX24Z_m9ScjB_umnbuBQBgLFwngakIzrFBo_pcSYiIWhxsaOEKaSxBiqLfnWiZI604QZkxNuIso1zjlVilnzGdl1b6F1CgGUDlrf3e99-dpGeSCPRjF31TphlG6V1mJCVRvBcKsyokG8ZBEr4IBV3u7_lzbbzO0_XU4ry3hwH91zLq2_U8vgA7RmRg_R7Rrkcv4IXbVxC78cFhCZ96E0oZIIv4Io94dza1FBUge-FXi7p9VYNvcXfablYDD3-0N32x0WMQ4PNQBDrP32xrxfg2KXj9HZjTDiCeqMipF5hnylklzyVOc41pRgldE0M8Y6a1oryUzuIdxsuVCuFzpAcgxElZOPUlGzSVg2iYpNIvbQ-_adcd0J5NrZu8DJdiZ08a4eFJMfwikFEaeaU52GOpeGZlhJLnGayARgAew51ZK50ciBcKqlFIsfwUNv2mGrFCDTI0emmNVzYqiRZh56WotNS0kUg9vGQw-xJYFaInV5ZNS_rBqP27Mt9Eby0IdG9BZkXbcVm7V4Ln1hr_9tp9qMYjITPLFnPA9drJhXn0KFa311KQYzURox_iumLfKQGS1lLKyvmglr-bXgmGKBNSYqZjLC1BLxbsXi7tHPPqwJsYAUP79-z1-jO93Tk2NxfNg7eoHuEiiGCXGAyQbqTCcz89K6qNPsldMDPvp-06rnDyKrqV8 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKKxAXxJtAgSBRLhBt7DhxfKhQS1u1FKoKUVT1YhzboSt2N6Xpqtq_yK9iJnFSFqreeo29jtczmZdn5iPkNVjxRqY2i0QW84hryiNtYxMJx3TmhCy0xnjH571s-4B_PEwPF8jvrhYG0yo7mdgIalsZjJEP0NIHZc2zbFD6tIj9ja33J78iRJDCm9YOTkN7mAW72rQb80Ueu252Du5cvbqzAbRfYWxr8-uH7cgjDkRGxOlZxAppc2wClTPnEhHHljoYYcJkmXPcwl8Bg0rbwjLhXMmkS7i0tJTcGAGqNIF1b5AlAVofHMGl9c29_S99xAfv1DiVvnInTvJBDdoTK9wYxQzLhEfpnHZsQAQus3z_T-Dsb3H_6XjaaMmtu-SON2_DtZYf75EFN7lPbraAl7MH5LyPYYT1uMIofYhlCg13hA1ceTiegXZFrh2FwPxwps1YMQsvek7r0WgWDsc-8x0XcR4bNUKlbMM-ez5sAbLrh-TgWgjxiCxOqol7QkJjslLL3JY0tZxRU_C8cA4MN2uNFq4MCO2OXBnfFx3hOUaquZ9PctWSSQGZVEMmlQbkbf-bk7YryJWz15GS_Uzs6N08qE5_KC8gVJpbyW0e21I7XlCjpaZ5pjOECACfFba53PGB8mKmVhcfRUBe9cMgIPDWR09cNW3npFgvLQLyuGWbfidJiiacjAMi5hhqbqvzI5PhcdOEHPxc7JMUkHcd611s66qjWGnZc-4NG8Nva81hVKdTJTPw9wJydMm81iNVvg3WsRpNVe3UyV_xbVXGwlmtUwV2a6HACrBKUk4VtZSZVOiEctjEm0sW949-DnFNjAvk9OnVZ_6S3AIRpD7t7O0-I7cZ1sXENKJsmSyenU7dc7BWz4oXXgyE5Pt1S54_Kvutow |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improving+smoking+cessation+after+myocardial+infarction+by+systematically+implementing+evidence-based+treatment+methods&rft.jtitle=Scientific+reports&rft.au=Leosdottir+Margret&rft.au=W%C3%A4rjerstam+Sanne&rft.au=Michelsen+Halldora+%C3%96gmundsdottir&rft.au=Schlyter+Mona&rft.date=2022-01-12&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-021-04634-5&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |